Synergistic Interaction between Candida albicans and Commensal Oral Streptococci in a Novel In Vitro Mucosal Model

ABSTRACT Candida albicans is a commensal colonizer of the gastrointestinal tract of humans, where it coexists with highly diverse bacterial communities. It is not clear whether this interaction limits or promotes the potential of C. albicans to become an opportunistic pathogen. Here we investigate the interaction between C. albicans and three species of streptococci from the viridans group, which are ubiquitous and abundant oral commensal bacteria. The ability of C. albicans to form biofilms with Streptococcus oralis, Streptococcus sanguinis, or Streptococcus gordonii was investigated using flow cell devices that allow abiotic biofilm formation under salivary flow. In addition, we designed a novel flow cell system that allows mucosal biofilm formation under conditions that mimic the environment in the oral and esophageal mucosae. It was observed that C. albicans and streptococci formed a synergistic partnership where C. albicans promoted the ability of streptococci to form biofilms on abiotic surfaces or on the surface of an oral mucosa analogue. The increased ability of streptococci to form biofilms in the presence of C. albicans could not be explained by a growth-stimulatory effect since the streptococci were unaffected in their growth in planktonic coculture with C. albicans. Conversely, the presence of streptococci increased the ability of C. albicans to invade organotypic models of the oral and esophageal mucosae under conditions of salivary flow. Moreover, characterization of mucosal invasion by the biofilm microorganisms suggested that the esophageal mucosa is more permissive to invasion than the oral mucosa. In summary, C. albicans and commensal oral streptococci display a synergistic interaction with implications for the pathogenic potential of C. albicans in the upper gastrointestinal tract.

[1]  L. C. Dutton,et al.  Streptococcus gordonii Modulates Candida albicans Biofilm Formation through Intergeneric Communication , 2009, Infection and Immunity.

[2]  Y. Tselentis,et al.  Prospective Evaluation of the Impact of Amoxicillin, Clarithromycin and Their Combination on Human Gastrointestinal Colonization by Candida Species , 2001, Chemotherapy.

[3]  R. Palmer,et al.  Microscopy flowcells: perfusion chambers for real-time study of biofilms. , 1999, Methods in enzymology.

[4]  E. Carlson Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice , 1983, Infection and immunity.

[5]  J. Wingard,et al.  Infection and mucosal injury in cancer treatment. , 2001, Journal of the National Cancer Institute. Monographs.

[6]  R. Kolter,et al.  Pseudomonas-Candida Interactions: An Ecological Role for Virulence Factors , 2002, Science.

[7]  G. Forrest Gastrointestinal infections in immunocompromised hosts , 2004, Current opinion in gastroenterology.

[8]  A. Dongari-Bagtzoglou,et al.  Development of a highly reproducible three-dimensional organotypic model of the oral mucosa , 2006, Nature Protocols.

[9]  R. Grillot,et al.  Candidaemia in Europe: epidemiology and resistance. , 2006, International journal of antimicrobial agents.

[10]  R. Gibbons,et al.  Proportional Distribution and Relative Adherence of Streptococcus miteor (mitis) on Various Surfaces in the Human Oral Cavity , 1972, Infection and immunity.

[11]  Y. Ha,et al.  Hypoxia-induced expression of VEGF in the organotypic spinal cord slice culture , 2011, Neuroreport.

[12]  M. Meyer,et al.  Host-Pathogen Interactions in Bacterial Endocarditis: Streptococcal Virulence in the Host , 1997, Advances in dental research.

[13]  G. Richards,et al.  The epidemiology of sepsis. , 1973, Clinical orthopaedics and related research.

[14]  A. Dongari-Bagtzoglou,et al.  The Host Cytokine Responses and Protective Immunity in Oropharyngeal Candidiasis , 2005, Journal of dental research.

[15]  P. Jolicoeur,et al.  Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection , 2004, Clinical Microbiology Reviews.

[16]  A. Nobbs,et al.  Interaction of Candida albicans Cell Wall Als3 Protein with Streptococcus gordonii SspB Adhesin Promotes Development of Mixed-Species Communities , 2010, Infection and Immunity.

[17]  R. Gibbons,et al.  Suppression of Candida albicans by Human Oral Streptococci in Gnotobiotic Mice , 1973, Infection and immunity.

[18]  R. Palmer,et al.  Molecular Characterization of Subject-Specific Oral Microflora during Initial Colonization of Enamel , 2006, Applied and Environmental Microbiology.

[19]  G. Pier,et al.  Mucosal Damage and Neutropenia Are Required for Candida albicans Dissemination , 2008, PLoS pathogens.

[20]  Hiroshi Nakagawa,et al.  Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. , 2003, Molecular cancer research : MCR.

[21]  A. Mitchell,et al.  Genetic control of Candida albicans biofilm development , 2011, Nature Reviews Microbiology.

[22]  Y. Tselentis,et al.  Effects of Doxycycline, Metronidazole and their Combination on Candida species Colonization of the Human Oropharynx, Intestinal Lumen and Vagina , 2003, Journal of chemotherapy.

[23]  Yong Zhu,et al.  Bacterial peptidoglycan triggers Candida albicans hyphal growth by directly activating the adenylyl cyclase Cyr1p. , 2008, Cell host & microbe.

[24]  P. Gopal,et al.  Adherence of Candida albicans to a cell surface polysaccharide receptor on Streptococcus gordonii , 1995, Infection and immunity.

[25]  P. Crowell,et al.  Cell Cycle Arrest by the Isoprenoids Perillyl Alcohol, Geraniol, and Farnesol Is Mediated by p21Cip1 and p27Kip1 in Human Pancreatic Adenocarcinoma Cells , 2007, Journal of Pharmacology and Experimental Therapeutics.

[26]  D. Graves,et al.  Interaction of oral bacteria with gingival epithelial cell multilayers. , 2011, Molecular oral microbiology.

[27]  H. Jenkinson,et al.  Candida albicans binding to the oral bacterium Streptococcus gordonii involves multiple adhesin-receptor interactions , 1996, Infection and immunity.

[28]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[29]  H. Harmsen,et al.  Oral Biofilm Architecture on Natural Teeth , 2010, PloS one.

[30]  H. Jenkinson,et al.  Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans , 1990, Infection and immunity.

[31]  Pan‐Chyr Yang,et al.  Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. , 2002, Microbial drug resistance.

[32]  T. Shimoda,et al.  Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[33]  P. Diaz,et al.  Characterization of Mucosal Candida albicans Biofilms , 2009, PloS one.

[34]  E. Carlson,et al.  Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality , 1982, Infection and immunity.

[35]  J. Lopez-Ribot,et al.  Engineered Control of Cell Morphology In Vivo Reveals Distinct Roles for Yeast and Filamentous Forms of Candida albicans during Infection , 2003, Eukaryotic Cell.

[36]  B. Dale,et al.  Antimicrobial peptides in the oral environment: expression and function in health and disease. , 2005, Current issues in molecular biology.

[37]  C. Dawes,et al.  Estimation of the Velocity of the Salivary Film at Some Different Locations in the Mouth , 1989, Journal of dental research.

[38]  B. Peters,et al.  Microbial interactions and differential protein expression in Staphylococcus aureus –Candida albicans dual-species biofilms , 2010, FEMS immunology and medical microbiology.

[39]  Po-Ren Hsueh,et al.  Current challenges in the management of invasive fungal infections , 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[40]  L. Samaranayake,et al.  (B1) Candida and Mycotic Infections , 2006, Advances in dental research.

[41]  A. P. Barrett Recognition and management of invasive pharyngeal candidiasis in acute leukemia. , 1989, Oral surgery, oral medicine, and oral pathology.

[42]  Annette Moter,et al.  Dental plaque biofilms: communities, conflict and control. , 2011, Periodontology 2000.

[43]  D. Hogan,et al.  Fungal--bacterial interactions: a mixed bag of mingling microbes. , 2006, Current opinion in microbiology.

[44]  M. Herlyn,et al.  Epidermal Growth Factor Receptor Mediates Increased Cell Proliferation, Migration, and Aggregation in Esophageal Keratinocytes in Vitro and in Vivo * , 2003, The Journal of Biological Chemistry.

[45]  S. Mallya,et al.  A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia. , 2009, Medical mycology.

[46]  A. Mitchell,et al.  Transcriptional Responses of Candida albicans to Epithelial and Endothelial Cells , 2009, Eukaryotic Cell.

[47]  P. Fidel,et al.  Candida-Host Interactions in HIV Disease , 2011, Advances in dental research.

[48]  J. Lopez-Ribot,et al.  Oral Candida Isolates Colonizing or Infecting Human Immunodeficiency Virus-Infected and Healthy Persons in Mexico , 2005, Journal of Clinical Microbiology.

[49]  A. Mitchell,et al.  Mucosal Tissue Invasion by Candida albicans Is Associated with E-Cadherin Degradation, Mediated by Transcription Factor Rim101p and Protease Sap5p , 2007, Infection and Immunity.

[50]  J. A. Barnett A history of research on yeasts 12: medical yeasts part 1, Candida albicans , 2008, Yeast.

[51]  M. Whiteway,et al.  Roles of the Candida albicansMitogen-Activated Protein Kinase Homolog, Cek1p, in Hyphal Development and Systemic Candidiasis , 1998, Infection and Immunity.

[52]  P. Kolenbrander,et al.  Mutualism versus Independence: Strategies of Mixed-Species Oral Biofilms In Vitro Using Saliva as the Sole Nutrient Source , 2001, Infection and Immunity.

[53]  L. Weisman,et al.  Neonatal Coinfection Model of Coagulase-Negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: Fluconazole Prophylaxis Enhances Survival and Growth , 2007, Antimicrobial Agents and Chemotherapy.

[54]  Zhihong Xie,et al.  A quantitative real-time RT-PCR assay for mature C. albicans biofilms , 2011, BMC Microbiology.

[55]  J. Izard,et al.  The Human Oral Microbiome , 2010, Journal of bacteriology.

[56]  J. A. Aas,et al.  Defining the Normal Bacterial Flora of the Oral Cavity , 2005, Journal of Clinical Microbiology.

[57]  R. Hancock,et al.  Immunomodulatory Properties of Defensins and Cathelicidins , 2006, Current topics in microbiology and immunology.

[58]  G. Sasso,et al.  Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study. , 2011, International journal of radiation oncology, biology, physics.

[59]  K. Fukase,et al.  Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. , 2007, Molecular immunology.

[60]  J. Köhler,et al.  Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle , 2010, PLoS pathogens.

[61]  C. C. Villar,et al.  Candida albicans induces early apoptosis followed by secondary necrosis in oral epithelial cells. , 2010, Molecular oral microbiology.

[62]  K. Sayama,et al.  Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. , 2005, The Journal of antimicrobial chemotherapy.

[63]  N. Grimaudo,et al.  Coaggregation of Candida albicans with oral Actinomyces species. , 1996, Oral microbiology and immunology.

[64]  M. Ghannoum,et al.  Cloning and Disruption of caPLB1, a Phospholipase B Gene Involved in the Pathogenicity of Candida albicans * , 1998, The Journal of Biological Chemistry.

[65]  T. Thurnheer,et al.  Automated fluorescent in situ hybridization for the specific detection and quantification of oral streptococci in dental plaque. , 2001, Journal of microbiological methods.